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Summary Information was obtained on the health status or cause of death in the mothers of a population-
based series of 143 children with soft tissue sarcomas. Among these mothers there were 6 cases of breast
cancer. All 6 women were pre-menopausal and 2 had bilateral disease. This represents a significant 3-fold
excess risk of breast cancer. Malignant disease had occurred in 6 other women whose ages at diagnosis ranged
from 33 to 58 years. This was not significantly in excess of expectation. The incidence of cancer among
mothers of various sub-groups of children was computed. For breast cancer mothers of: boys, children who
were less than the median age at diagnosis, and children who had pelvic tumours had a greater excess risk
than the group as a whole. Among those sub-groups of mothers the highest excess risk was 13.5. For other
cancers, no sub-group showed an incidence which was significantly above the expected. A high proportion of
infiltrating lobular carcinoma was found among the breast cancers, and histological type may indicate familial
disease. These findings are consistent with the cancer family syndrome described by Li & Fraumeni in 1969,
but the present results suggest that a higher proportion of childhood soft tissue sarcoma than was hitherto
suspected may have a genetic aetiology. Further pedigree and laboratory studies may help to identify familial
cases at the time of the child's diagnosis.
Soft tissue sarcomas represent about 6% of all
childhood cancer and over half of the cases are
embryonal rhabdomyosarcomas (Birch et al., 1980).
In 1969 a cancer family syndrome involving soft
tissue sarcomas in children and early onset cancers
in close relatives, especially breast cancer in the
mothers, was described (Li & Fraumeni, 1969).
Members of the 4 families initially reported have
been followed up for a number of years and further
cancers have developed (Li & Fraumeni, 1982).
Other kindreds showing a similar array of tumours
have been reported (Bottomly et al., 1971; Lynch et
al., 1978; Blattner et al., 1979; Pearson et al., 1982;
Duncan & Miller, 1983), and it has been suggested
that there is a role for surveillance programmes
aimed at early diagnosis and treatment amongst
these families (Li & Fraumeni, 1975, 1982).
However, all these kindreds have been ascertained
by chance, or by investigating the extended
pedigree of cases with a known family history of
cancer, for example, sibling pairs of soft tissue
sarcoma.
Whether there is an increased risk of developing
cancer among the mothers of all children with soft
tissue sarcoma is unknown and cannot be
determined from existing case reports in the
literature. An effective surveillance programme and
appropriate genetic counselling would depend on
such knowledge. In order to estimate this risk, an
attempt was made to ascertain current health or
cause of death of the mothers of all cases of soft
tissue sarcoma included in the Manchester
Children's Tumour Registry between 1954 and
1981. Other factors, such as the precise histology in
the child, the site of the child's tumour, age at
diagnosis, and sex, were also considered in relation
to the mother's present health. The possibility of
identifying families at greatest risk at the time of
diagnosis of the index child, whether or not there is
a family history of malignant disease at that time,
was examined.
Methods
All cases of soft tissue sarcoma in the Manchester
Children's Tumour Registry (MCTR) who were
diagnosed between January 1st 1954 and December
31st 1981 were included in the study. The MCTR is
population based. Ascertainment has been
estimated to be 95-98% complete (Leck et al.,
1976). Review of histology slides by a panel of
expert pathologists ensures diagnostic accuracy.
Pathological material is retained by the Registry so
that diagnoses can be reviewed with advances in
knowledge and the development of new staining
techniques. The MCTR is described in detail in
Birch et al. (1980).
The histology slides of all possible cases of soft
tissue sarcoma, including those with equivocal
diagnoses, were reviewed for the purposes of the
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present study to ensure as complete and accurate a
series as possible. The tumours were classified as
follows: embryonal rhabdomyosarcoma; adult
pleomorphic rhabdomyosarcoma; fibrosarcoma;
fibrous histiocytoma; embryonal sarcoma;
haemangiopericytoma; synovial sarcoma, and other
rare soft tissue sarcomas. Embryonal
rhabdomyosarcoma was further sub-classified into
loose (non-botryoid and botryoid), dense, alveolar
and embryonal not otherwise specified.
In addition to the histological review, the case
records of all the children included were abstracted
with respect to the following: site of the primary
tumour; age at diagnosis; sex; and details of the
mother if these were present in the child's notes.
Primary site of the child's tumour was classified,
using a scheme similar to that described in Enzinger
& Weiss (1983), as follows: head and neck; genito-
urinary and other intrapelvic; peripheral soft tissues
of trunk; soft tissues of limb; and other. Median
age at diagnosis was calculated.
The locations of the mothers' present general
practitioners (GPs) were found, using a variety of
techniques. Where sufficient detail was present in
the child's notes, the current Family Practitioner
Committee (FPC) was contacted; in other cases the
National Health Service Central Register was able
to give us the mother's present FPC. Where the
child's hospital of birth was known details of the
mother could sometimes be found in the obstetric
notes. Other sources of information included birth
registrations, electoral rolls and local history
departments.
When the mother's GP had been located, a
questionnaire asking specifically about neoplastic
disease, other chronic disease and the mother's
present state of health was sent. A search for the
mothers' names in the records of the North West
Regional Cancer Register was also made. If a
mother had died, the cause of death was
ascertained via medical records. Where malignant
disease was reported in the mother, the hospital
case notes were abstracted and histology slides were
obtained and reviewed.
The cumulative risks with age of breast cancer
and other cancers were estimated, using population
data for the North West Region (North Western
Regional Health Authority 1982), and used to
compute expected numbers of cancers among the
mothers, taking into account their age at last
follow-up. This was taken as their age in completed
years on the date on which the questionnaire was
completed by the GP, or age at death as
appropriate. Relative risk ratios were calculated by
comparing expected numbers of cancers among the
mothers with observed numbers. The significance
was tested using the method described by Rothman
& Boice (1982) for exact testing and estimation for
a poisson variate, except that a two-tailed test was
performed, rather than a one-tail, because it was
not known whether there would be an increased or
decreased incidence of cancers among the mothers.
Results
After review of histology there were 150 cases
which were considered eligible for the study. Of
these 93 were boys and 57 were girls. The median
age at diagnosis for all cases considered together
was 4 years and 1 month. The distribution of
histological types among the cases is shown in
Table I. There were 92 embryonal rhabdomyo-
Table I Index child
Distribution ofhistological types
All cases
No. %
Embryonal rhabdomyosarcoma
Loose
Dense
Alveolar
Embryonal NOS
TOTAL
Other soft tissue sarcoma
Fibrosarcoma
Fibrous histiocytoma
Embryonal sarcoma
Haemangiopericytoma
Synovial sarcoma
Other
TOTAL
18 12
51 34
20 13
3 2
92 61
7
5
11
5
5
25
58
5
3
7
3
3
17
38
sarcomas. Of the remaining soft tissue sarcomas,
embryonal sarcoma was most common, followed
by fibrosarcoma. Other cases included haemangio-
pericytoma, liposarcoma, neurofibrosarcoma,
triton tumour and leiomyosarcoma. Three cases of
pleomorphic adult type rhabdomyosarcoma are
included in the "other" category. Table II shows
the distribution by primary site. The most common
anatomical locations were within the head and neck
region, and in the pelvis.
Three of the 150 children were adopted, and
consequently no information was available on their
mothers. Medical information on the current health
status or cause of death of 136 of the remaining
mothers was obtained. Some information on
mother's health was available in the MCTR recordsEXCESS RISK OF BREAST CANCER 327
Table II Index child
Distribution primary site
All cases
No. %
Head and neck 60 40
Genito-urinary and other intra-
pelvic 48 32
Peripheral soft tissues trunk 12 8
Soft tissues limbs 22 15
Other 8 5
of a further 7 children. In these latter 7 cases the
age at last follow-up was considered to be that at
the time of the most recent entry concerning the
mother's health. The median age of the mothers at
last follow-up was 44 years (inter-quartile range 38-
54). Among the 143 mothers for whom information
was obtained, there were 12 cases of malignant
disease - 6 breast cancers and 6 other cancers of
various sites and histological types. Six of these
mothers had died of their malignant disease; one
other mother had died in a road traffic accident; all
other mothers were alive at the time of their last
follow-up. Histological material was available from
all 12 of the cancers and was reviewed especially
for this study.
Table III shows the histological types of breast
cancers, their laterality and the age at diagnosis.
The age at diagnosis, sex, histology and site of
tumour in their respective children with soft tissue
sarcoma is also shown in this table. Two of the
mothers had bilateral breast tumours. In both
women the tumours were considered to be separate
primaries on histological grounds. In one of the
bilateral cases both tumours showed the presence of
in situ elements. This feature is regarded as the best
criterion for distinguishing separate primaries from
metastases to the other breast. In the second
bilateral case, in situ carcinoma was not seen, but
the histological pattern found in each of the
tumours was so different it was considered that
these were separate primaries. Of the 8 tumours
among these 6 women, 4 showed lobular features
and 2 showed tubular features (1 tumour being a
tubulo-lobular carcinoma, lobular element
dominant). The ages of the women at diagnosis
ranged from 27 to 53.
Table IV shows the histological types, sites, ages
at diagnoses among the mothers with other cancers,
and similar details for their respective children with
soft tissue sarcomas. Their ages at diagnosis ranged
from 33 to 58, and the tumours included a
malignant glioma.
Expected and observed numbers of cancers
among the mothers as a whole and among the
mothers of various sub-groups of the children are
shown in Table V. The sub-groups were defined by
sex, primary site and whether the child was above
or below the median age at diagnosis. Sub-groups
defined by histology of the child's tumour were also
examined, but no group so defined was at
particularly high risk with respect to cancer in the
mothers. Among all the mothers whose health
status was known, there was a 3-fold excess risk
(P=0.01).
Among the mothers of various sub-groups of
children shown in the table, the highest relative risk
of developing breast cancer was seen among the
mothers of boys who were less than the median age
at diagnosis, and who had pelvic tumours. In this
group there were 0.3 cases of breast cancer
Table III Carcinoma breast in mothers ofchildren with soft tissue sarcoma
Mother Child
Histology Site Age Histology Site Age Sex
Infiltrating duct L 27 Dense poorly differentiated Middle 1 M
rhabdomyosarcoma ear
Infiltrating duct L 39 Dense poorly differentiated Perianal 3 F
rhabdomyosarcoma
Infiltrating lobular R 42 Loose botryoid rhabdomyo- Bladder 1 M
sarcoma
i) Tubular L 44 Loose non-botryoid rhabdo- Bladder 1 M
ii) Tubulo-lobular R 45 myosarcoma
Infiltrating lobular L 46 Fibrosarcoma Pelvis 3 M
i) Mixed infiltrating
duct/infiltrating L 53
lobular Malignant fibrous histiocytoma Pelvis <1 M
ii) Infiltrating duct R 55 j328 J.M. BIRCH et al.
Table IV Other malignancy in mothers ofchildren with soft tissue sarcoma
Mother Child
Histology Site Age Histology Site Age Sex
Anaplastic malignant Frontal & 33 Dense moderately Perianal <1 M
glioma temporal differentiated rhabdo-
lobe myosarcoma
Lymphoma, diffuse Cervical 45 Dense poorly differ- Thigh 12 M
centroblastic/ lymph entiated rhabdomyo-
centrocytic nodes sarcoma
Endometrioid Bilateral 46 Embryonal sarcoma Bladder 3 F
carcinoma ovary
Carcinoma of non- Post-nasal 56 Dense poorly differ- Thoracic 11 M
keratinizing type space entiated rhabdomyo- wall
sarcoma
Well differentiated Sigmoid 55 Embryonal sarcoma Mediastinum 4 F
adenocarcinoma colon loose and dense areas
Well differentiated Endometrium 58 Embryonal sarcoma Pelvis S F
adenocarcinoma
Table V Excess risk of cancer among mothers ofvarious sub-groups ofchildren with soft tissue sarcoma
Cancers in mother
Breast cancer Other cancer
Expected Observed Expected Observed
Sub-groups ofchildren (No.) number number R.R. P number number R.R. P
All cases where mother's
health status known (143) 2.0 6 3.0 0.01 4.5 6 1.3 0.2
Less than median age at
diagnosis (71) 0.8 6 7.6 0.0001 1.7 2 1.2 0.4
Genito-urinary or other
intra-pelvic tumour (45) 0.7 5 7.5 0.0004 1.5 3 2.1 0.1
Male (90) 1.2 5 4.2 0.01 2.6 3 1.2 0.4
Less than median age at
diagnosis, with genito-
urinary or other intra-
pelvic tumour (35) 0.5 5 10.8 0.0001 1.0 2 2 0.2
Male, less than median age
at diagnosis, with genito-
urinary or other intra-
pelvic tumour (25) 0.3 4 13.5 0.0001 0.6 1 1.6 0.3
expected, and 4 were observed. The relative risk
was 13.5 (P=0.0001). Among the corresponding
sub-groups, for example girls and children with
tumours at other sites, the expected numbers of
breast cancer did not differ significantly from the
numbers observed. The numbers of other cancers
found among these mothers was only slightly in
excess of the expected number, and was not
statistically significant (relative risk 1.3; P=0.2).
There was no association of these other cancers
with the mothers of any particular sub-group of
children. For the calculation of these relative risks,
bilateral tumours were considered to be one case,
although in some circumstances bilateral tumoursEXCESS RISK OF BREAST CANCER 329
may be registered separately in the Regional Cancer
Register. The relative risks shown in Table V are
therefore slightly under-estimated.
In addition to the malignant tumours shown in
the tables, 5 other cases of neoplastic disease
occurred amongst the mothers: 2 cases of uterine
fibroids, fibroma of the lung, lipoma of chest wall
and cervical carcinoma in situ. Since no population
data are available for these tumours the significance
of the 5 cases cannot be estimated.
Discussion
In this population-based study, the mothers of
children with soft tissue sarcoma experienced a
significantly increased incidence of carcinoma of the
breast, compared with the general female
population living in the same geographical region.
The overall risk to the mothers was 3-fold, but in
the present study population the mothers of
children in a particular sub-group defined by age of
the child at diagnosis, the primary site of the soft
tissue sarcoma, and the sex of the child, were at
substantially greater risk. It may be, therefore, that
among childhood soft tissue sarcomas there are two
fractions: one where inherited factors are the most
important element in aetiology, and a second
fraction where the genetic role is less marked.
Mothers of children in the first fraction would be at
greatest risk.
Previous reports of the association of breast
cancer with soft tissue sarcoma in families have
been anecdotal, and the families identified because
of the coincidence in time of 2 or more cases. The
present study indicates that the genetic fraction
among childhood soft tissue sarcoma may be
greater than hitherto suspected. In the literature 5
families have been described where the mothers of
children with soft tissue sarcoma had breast cancer,
and where the age of the child at diagnosis, the site
of the primary tumour and the sex of the child is
given. Among these families there were 7 children
with soft tissue sarcoma - 3 boys and 4 girls. All of
the children were 3 years of age or under at
diagnosis, 2 of them had pelvic tumours, 1 had a
tumour of the eye, 1 had a tumour of the paranasal
region and 3 had tumours of limbs (Li &
Fraumeni, 1982; Pearson et al., 1982; Duncan &
Miller, 1983). Comparing these findings with the
present series it may be that age at onset in the
child is the most important indicator of a possible
familial trait. Combining children reported in the
literature with those in the present series 7 (54%)
had pelvic tumours, which is a similar proportion
to the group as a whole.
The distribution of histologies seen in the breast
cancers among these mothers was unusual. In an
unselected series of 1068 patients with breast cancer
presenting to a local hospital 40 (3.7%) had
bilateral disease, giving a total of 1108 cancers. The
histology of these cancers was reviewed by one of
us (MH) and only 9% were lobular compared with
81% infiltrating duct. It is not possible to compare
the histology of the breast cancers found in the
present series with that of similar families
previously reported, because this information is not
available. However, histology has recently been
studied among the 31% of a series of 1024 women
consecutively treated for breast cancer who
reported at least one close female relative with
breast cancer (Rosen et al., 1982). In this study no
single histological type was consistently associated
with a high frequency of breast cancer in all classes
of relatives, although the highest frequency of
breast cancer among their sisters was found in
patients with lobular carcinoma. Bilaterality and
early age at onset have also been linked with
familial breast cancer (Lynch, 1981). The
occurrence of 2 cases of bilateral breast cancer out
of a total of 6 among the present series would
support a genetic aetiology. An association of
bilaterality with a high proportion of lobular and
tubular carcinoma of the breast has been noted by
some workers (Robbins & Berg, 1964; Finney et al.,
1972). Of the 80 cancers occurring in the 40
patients with bilateral disease described above 19%
were lobular. In the 2 mothers with bilateral disease
in the present series, 2 of the 4 cancers showed
some lobular features and 2 showed tubular
features, 1 being tubulo-lobular. This is especially
interesting in the context of the suggestion that
tubular carcinoma is histogenically related to
lobular carcinoma (Eusebi et al., 1979).
It has been suggested that familial breast cancer
has a better prognosis than sporadic (Albano et al.,
1982). Among the present 6 cases, 2 are still alive
20 years and 19 years respectively after diagnosis; a
third patient is alive nearly 3 years after diagnosis;
and a fourth patient died after 72 years. The
remaining 2 cases died within 2 years of diagnosis.
The crude survival rate for breast cancer in
England and Wales, 1971-1973, for females aged
between 35 and 54, was 59%-63% at 5 years
(Toms, 1982). Accurate assessment of survival
amongst hereditary cases of breast cancer compared
with sporadic cases requires larger series and
standardization for age, histology and stage at
presentation.
All 6 women with breast cancer in the present
series were pre-menopausal at diagnosis, as
confirmed from their medical records, and were
young compared with a median age at onset in the
population of between 60 and 64 years (North
Western Regional Health Authority, 1982). This
apparent early onset may be a reflection of the age330 J.M. BIRCH et al.
structure of this series of women. A follow-up of
these mothers over a number of years may reveal
the development of further cases of breast cancer as
the women become older, and thus the average age
at onset may increase. These findings indicate the
need to take an adequate family history from new
cases of breast cancer, particularly those with
bilateral disease and/or premenopausal onset.
Histological type may also be an indicator of
inherited disease. Recognition that the occurrence
of early onset cancer in close relatives could
indicate heritability may lead to the identification
of other women at risk with the possibility of early
detection and treatment.
The 6 other cancers to occur amongst this series
of mothers were mainly of unusual histological
types. The number of cases did not exceed
expectation, and therefore the array of histologies
seen may be a reflection of the age distribution of
this population of women.
The present study was specifically concerned with
the occurrence of malignant disease among the
mothers. However it is likely that other family
members may also be at risk of developing
malignant disease, and in this context in the present
series six of the children had siblings with tumours,
including one sib-pair where both children had soft
tissue sarcomas. The other siblings had adrenal
cortical tumour, Wilms' tumour, and two cases of
astrocytoma respectively. The mother of the child
whose sib had an adrenal cortical tumour
developed breast cancer at age 27 (Table III). This
family has previously been reported (Pearson et al.,
1982), and is a clear example of the syndrome
described by Li & Fraumeni (1969).
The maternal grandmother of the child whose
mother had a glioma (Table IV) is reported to have
died of breast cancer at the age of 42 years. This is
of particular interest since brain tumours are also a
common feature of the "Li-Fraumeni" type
families described in the literature. Furthermore,
the index child fits into the sub-group whose
mothers are at greatest risk for breast cancer as
found in the present study. It may be that in this
family the various cancers have a mainly genetic
aetiology and this mother accounts for the slight
excess of cancers other than breast found among
the whole group of mothers.
Clearly there is a need to obtain pedigree
histories from all of the families included in the
study in order to determine more accurately the
proportion of childhood soft tissue sarcomas which
have a predominantly genetic aetiology.
Some cancer-prone conditions, for example
xeroderma pigmentosum and ataxia telangectasia,
characteristically show in vitro sensitivity to killing
by UV light and gamma radiation respectively in
cells from patients with these disorders. Conversely,
cells from 2 patients who were members of the
family described by Blattner et al. (1979) showed in
vitro resistance to cell killing by gamma radiation
(Bech-Hansen et al., 1981). Further in vitro studies
on material obtained from members of such
families are obviously needed and may help to
elucidate patterns of inheritance by identifying
asymptomatic gene carriers in addition to
contributing to knowledge of mechanisms of
inheritance and malignant transformation at the
cellular and molecular level.
In conclusion, we have found a significantly
increased risk of developing breast cancer in the
mothers of children with soft tissue sarcomas, and
this excess risk is particularly marked in a certain
sub-group. It may therefore be possible to recognize
families at greatest risk at the time of the child's
diagnosis even in the absence of a positive family
history of malignant disease at that time. Further
pedigree studies of the group as a whole, and in
vitro studies among selected members of the
families, may clarify this aspect. This work is
important in that it offers the basis for more
enlightened genetic counselling to be given to
families of children with soft tissue sarcoma,
selecting patients who might benefit from screening
with the prospect of early diagnosis and more
effective treatment in those members of the families
at greatest risk. In addition, the work may
contribute to the understanding of the genetic
component in the aetiology of these diseases.
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